Columbia Partners Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-40,859
Closed -$5.08M 285
2017
Q1
$5.08M Sell
40,859
-6,310
-13% -$755K 0.65% 42
2016
Q4
$5.46M Sell
47,169
-8,710
-16% -$970K 0.49% 70
2016
Q3
$5.84M Buy
55,879
+13,754
+33% +$1.49M 0.46% 78
2016
Q2
$4.15M Sell
42,125
-9,527
-18% -$985K 0.31% 114
2016
Q1
$5.17M Buy
+51,652
New +$5.32M 0.37% 103

Other funds holding CELG

Columbia Partners Investment Management's CELG Position: Q2 2017 in Review

Columbia Partners Investment Management sold out of Celgene Corp (CELG) in Q2 2017, closing a stake of 40,859 shares — an estimated $5.08M sold.

Columbia Partners Investment Management first reported a position in CELG in Q1 2016 and held it in 5 quarters. The position peaked at $5.84M in Q3 2016. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.

  • Columbia Partners Investment Management reported no remaining Celgene Corp position as of Q2 2017 after selling out during the quarter.
  • Columbia Partners Investment Management sold 40,859 Celgene Corp shares in Q2 2017, an estimated $5.08M.
  • Columbia Partners Investment Management first reported a position in Celgene Corp in Q1 2016 and held it in 5 quarters.
  • Columbia Partners Investment Management's Celgene Corp position peaked at $5.84M in Q3 2016.
  • 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.

Based on Columbia Partners Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.